vs
ExlService Holdings, Inc.（EXLS）とPennant Group, Inc.（PNTG）の財務データ比較。上の社名をクリックして会社を切り替えられます
ExlService Holdings, Inc.の直近四半期売上が大きい（$542.6M vs $289.3M、Pennant Group, Inc.の約1.9倍）。ExlService Holdings, Inc.の純利益率が高く（11.1% vs 3.0%、差は8.1%）。Pennant Group, Inc.の前年同期比売上増加率が高い（53.2% vs 12.7%）。ExlService Holdings, Inc.の直近四半期フリーキャッシュフローが多い（$106.5M vs $17.4M）。過去8四半期でPennant Group, Inc.の売上複合成長率が高い（35.8% vs 11.5%）
ExlService Holdings Inc.は保険、ヘルスケア、銀行・金融サービス、メディア、小売などの業界を対象に分析・デジタルソリューションを提供するグローバル企業で、本社はニューヨークに所在し、米国、欧州、アジア、中南米、オーストラリア、南アフリカなど世界各地に5万4000人以上の専門スタッフを擁しています。
ペナントグループ株式会社は米国に本社を置く医療サービス事業者で、在宅医療、ホスピスケア、高齢者向け居住ソリューション、熟練看護支援を提供しています。米国の数十州で事業を展開し、主に高齢者や医療的ケアを必要とする弱者層を対象としてサービスを提供しています。
EXLS vs PNTG — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $542.6M | $289.3M |
| 純利益 | $60.2M | $8.6M |
| 粗利率 | 38.6% | — |
| 営業利益率 | 14.4% | 6.0% |
| 純利益率 | 11.1% | 3.0% |
| 売上前年比 | 12.7% | 53.2% |
| 純利益前年比 | 18.9% | 50.0% |
| EPS（希薄化後） | $0.38 | $0.25 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $542.6M | $289.3M | ||
| Q3 25 | $529.6M | $229.0M | ||
| Q2 25 | $514.5M | $219.5M | ||
| Q1 25 | $501.0M | $209.8M | ||
| Q4 24 | $481.4M | $188.9M | ||
| Q3 24 | $472.1M | $180.7M | ||
| Q2 24 | $448.4M | $168.7M | ||
| Q1 24 | $436.5M | $156.9M |
| Q4 25 | $60.2M | $8.6M | ||
| Q3 25 | $58.2M | $6.1M | ||
| Q2 25 | $66.1M | $7.1M | ||
| Q1 25 | $66.6M | $7.8M | ||
| Q4 24 | $50.7M | $5.8M | ||
| Q3 24 | $53.0M | $6.2M | ||
| Q2 24 | $45.8M | $5.7M | ||
| Q1 24 | $48.8M | $4.9M |
| Q4 25 | 38.6% | — | ||
| Q3 25 | 38.5% | — | ||
| Q2 25 | 37.7% | — | ||
| Q1 25 | 38.6% | — | ||
| Q4 24 | 38.1% | — | ||
| Q3 24 | 37.8% | — | ||
| Q2 24 | 37.1% | — | ||
| Q1 24 | 37.4% | — |
| Q4 25 | 14.4% | 6.0% | ||
| Q3 25 | 14.4% | 4.5% | ||
| Q2 25 | 15.8% | 5.3% | ||
| Q1 25 | 15.7% | 6.0% | ||
| Q4 24 | 14.8% | 4.9% | ||
| Q3 24 | 14.7% | 6.0% | ||
| Q2 24 | 13.7% | 5.7% | ||
| Q1 24 | 14.1% | 5.4% |
| Q4 25 | 11.1% | 3.0% | ||
| Q3 25 | 11.0% | 2.7% | ||
| Q2 25 | 12.8% | 3.2% | ||
| Q1 25 | 13.3% | 3.7% | ||
| Q4 24 | 10.5% | 3.0% | ||
| Q3 24 | 11.2% | 3.4% | ||
| Q2 24 | 10.2% | 3.4% | ||
| Q1 24 | 11.2% | 3.1% |
| Q4 25 | $0.38 | $0.25 | ||
| Q3 25 | $0.36 | $0.17 | ||
| Q2 25 | $0.40 | $0.20 | ||
| Q1 25 | $0.40 | $0.22 | ||
| Q4 24 | $0.31 | $0.16 | ||
| Q3 24 | $0.33 | $0.20 | ||
| Q2 24 | $0.28 | $0.18 | ||
| Q1 24 | $0.29 | $0.16 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $328.4M | — |
| 総負債低いほど良い | $298.6M | $168.8M |
| 株主資本純資産 | $912.7M | $374.3M |
| 総資産 | $1.7B | $968.2M |
| 負債/資本比率低いほどレバレッジが低い | 0.33× | 0.45× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $328.4M | — | ||
| Q3 25 | $390.1M | — | ||
| Q2 25 | $353.3M | — | ||
| Q1 25 | $331.4M | — | ||
| Q4 24 | $340.6M | — | ||
| Q3 24 | $325.8M | — | ||
| Q2 24 | $276.1M | — | ||
| Q1 24 | $246.2M | — |
| Q4 25 | $298.6M | $168.8M | ||
| Q3 25 | $354.8M | $26.0M | ||
| Q2 25 | $260.0M | $37.0M | ||
| Q1 25 | $307.3M | $52.5M | ||
| Q4 24 | $288.5M | $0 | ||
| Q3 24 | $344.7M | $108.9M | ||
| Q2 24 | — | $82.2M | ||
| Q1 24 | — | $83.3M |
| Q4 25 | $912.7M | $374.3M | ||
| Q3 25 | $952.4M | $343.0M | ||
| Q2 25 | $1.1B | $333.6M | ||
| Q1 25 | $1.0B | $323.0M | ||
| Q4 24 | $929.9M | $312.0M | ||
| Q3 24 | $907.6M | $187.3M | ||
| Q2 24 | $852.6M | $173.0M | ||
| Q1 24 | $803.3M | $164.2M |
| Q4 25 | $1.7B | $968.2M | ||
| Q3 25 | $1.7B | $753.6M | ||
| Q2 25 | $1.7B | $751.4M | ||
| Q1 25 | $1.7B | $743.6M | ||
| Q4 24 | $1.6B | $679.5M | ||
| Q3 24 | $1.6B | $646.8M | ||
| Q2 24 | $1.5B | $602.5M | ||
| Q1 24 | $1.4B | $578.2M |
| Q4 25 | 0.33× | 0.45× | ||
| Q3 25 | 0.37× | 0.08× | ||
| Q2 25 | 0.25× | 0.11× | ||
| Q1 25 | 0.30× | 0.16× | ||
| Q4 24 | 0.31× | 0.00× | ||
| Q3 24 | 0.38× | 0.58× | ||
| Q2 24 | — | 0.48× | ||
| Q1 24 | — | 0.51× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $117.4M | $21.0M |
| フリーキャッシュフロー営業CF - 設備投資 | $106.5M | $17.4M |
| FCFマージンFCF / 売上 | 19.6% | 6.0% |
| 設備投資強度設備投資 / 売上 | 2.0% | 1.2% |
| キャッシュ転換率営業CF / 純利益 | 1.95× | 2.43× |
| 直近12ヶ月FCF直近4四半期 | $298.1M | $36.3M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $117.4M | $21.0M | ||
| Q3 25 | $120.7M | $13.9M | ||
| Q2 25 | $109.4M | $34.6M | ||
| Q1 25 | $3.2M | $-21.2M | ||
| Q4 24 | $105.3M | $20.6M | ||
| Q3 24 | $110.1M | $7.7M | ||
| Q2 24 | $74.9M | $10.5M | ||
| Q1 24 | $-21.9M | $545.0K |
| Q4 25 | $106.5M | $17.4M | ||
| Q3 25 | $106.4M | $10.5M | ||
| Q2 25 | $95.0M | $31.6M | ||
| Q1 25 | $-9.7M | $-23.2M | ||
| Q4 24 | $95.3M | $17.2M | ||
| Q3 24 | $97.3M | $6.8M | ||
| Q2 24 | $62.8M | $8.9M | ||
| Q1 24 | $-33.1M | $-2.6M |
| Q4 25 | 19.6% | 6.0% | ||
| Q3 25 | 20.1% | 4.6% | ||
| Q2 25 | 18.5% | 14.4% | ||
| Q1 25 | -1.9% | -11.1% | ||
| Q4 24 | 19.8% | 9.1% | ||
| Q3 24 | 20.6% | 3.8% | ||
| Q2 24 | 14.0% | 5.3% | ||
| Q1 24 | -7.6% | -1.7% |
| Q4 25 | 2.0% | 1.2% | ||
| Q3 25 | 2.7% | 1.5% | ||
| Q2 25 | 2.8% | 1.4% | ||
| Q1 25 | 2.6% | 0.9% | ||
| Q4 24 | 2.1% | 1.8% | ||
| Q3 24 | 2.7% | 0.5% | ||
| Q2 24 | 2.7% | 1.0% | ||
| Q1 24 | 2.6% | 2.0% |
| Q4 25 | 1.95× | 2.43× | ||
| Q3 25 | 2.08× | 2.29× | ||
| Q2 25 | 1.66× | 4.89× | ||
| Q1 25 | 0.05× | -2.73× | ||
| Q4 24 | 2.08× | 3.57× | ||
| Q3 24 | 2.08× | 1.24× | ||
| Q2 24 | 1.63× | 1.84× | ||
| Q1 24 | -0.45× | 0.11× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
EXLS
| Insurance | $185.8M | 34% |
| Healthcare And Life Sciences | $142.2M | 26% |
| Banking Capital Markets And Diversified Industries | $122.6M | 23% |
| International Growth Markets | $92.0M | 17% |
PNTG
| Home Health Subsegment | $136.2M | 47% |
| Hospice Subsegment | $97.1M | 34% |
| Private And Other | $36.4M | 13% |
| Medicare And Medicaid | $19.6M | 7% |
| Affiliated Entity | $2.2M | 1% |
